Profiling of Pharmacogenomic Variants in CYP2D6 and DPYD in Indigenous Arab Breast Cancer Patients

References

• Sung H , FerlayJ , SiegelRLet al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Barakeh DH , AljelaifyR , BashawriYet al. Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients. Oncotarget12(7), 686–697 (2021).
   PubMedGoogle Scholar
• Hashim MJ , Al-ShamsiFA , Al-MarzooqiNA , Al-QasemiSS , MokdadAH , KhanG. Burden of breast cancer in the Arab world: findings from global burden of disease, 2016. J. Epidemiol. Glob. Health8(1–2), 54–58 (2018).
   PubMed Web of Science ®Google Scholar
• Dean L . Tamoxifen therapy and CYP2D6 genotype. In: Medical Genetics Summaries.PrattVM, ScottSA, PirmohamedMet al.et al. ( Eds). National Center for Biotechnology Information, MD, USA (2014).
   Google Scholar
• Madlensky L , NatarajanL , TchuSet al. Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes. Clin. Pharmacol. Ther.89(5), 718–725 (2011).
   PubMed Web of Science ®Google Scholar
• Borges S , DestaZ , LiLet al. Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Clin. Pharmacol. Ther.80(1), 61–74 (2006).
   PubMed Web of Science ®Google Scholar
• Jung J-A , LimH-S. Association between CYP2D6 genotypes and the clinical outcomes of adjuvant tamoxifen for breast cancer: a meta-analysis. Pharmacogenomics15(1), 49–60 (2014).
   PubMed Web of Science ®Google Scholar
• Amstutz U , HenricksLM , OfferSMet al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update. Clin. Pharmacol. Ther.103(2), 210–216 (2018).
   PubMed Web of Science ®Google Scholar
• Lauschke VM , MilaniL , Ingelman-SundbergM. Pharmacogenomic biomarkers for improved drug therapy – recent progress and future developments. AAPS J.20(1), 4 (2017).
   PubMed Web of Science ®Google Scholar
• Jeibouei S , AkbariME , KalbasiAet al. Personalized medicine in breast cancer: pharmacogenomics approaches. Pharmgenomics Pers. Med.12, 59–73 (2019).
   PubMed Web of Science ®Google Scholar
• Ortega VE , MeyersDA. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J. Allergy Clin. Immunol.133(1), 16–26 (2014).
   PubMed Web of Science ®Google Scholar
• Abou Tayoun AN , RehmHL. Genetic variation in the Middle East – an opportunity to advance the human genetics field. Genome Med.12(1), 116 (2020).
   PubMed Web of Science ®Google Scholar
• Goljan E , AbouelhodaM , ElKaliobyMMet al. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population. PLoS One17(1), e0263137 (2022).
   PubMed Web of Science ®Google Scholar
• Broad Institute . Picard toolkit (2019). https://github.com/broadinstitute/picard
   Google Scholar
• Birger C , HannaM , SalinasEet al. FireCloud, a scalable cloud-based platform for collaborative genome analysis: strategies for reducing and controlling costs. bioRxiv 209494 doi: https://doi.org/10.1101/209494 (2017).
   Google Scholar
• McKenna A , HannaM , BanksEet al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res.20(9), 1297–1303 (2010).
   PubMed Web of Science ®Google Scholar
• Li H , DurbinR. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics25(14), 1754–1760 (2009).
   PubMed Web of Science ®Google Scholar
• Van der Auwera GA , CarneiroMO , HartlCet al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinformatics43, 11.10.1–11.10.33 (2013).
   PubMedGoogle Scholar
• McKinney W . Data structures for statistical computing in Python. Presented at: Proceedings of the 9th Python in Science Conference.Austin, TX, USA, 28 June–3 July 2010.
   Google Scholar
• Poplin R , ChangP-C , AlexanderDet al. A universal SNP and small-indel variant caller using deep neural networks. Nat. Biotechnol.36(10), 983–987 (2018).
   PubMed Web of Science ®Google Scholar
• Camp SY , KofmanE , ReardonBet al. Evaluating the molecular diagnostic yield of joint genotyping-based approach for detecting rare germline pathogenic and putative loss-of-function variants. Genet. Med.23(5), 918–926 (2021).
   PubMed Web of Science ®Google Scholar
• AlDubayan SH , ConwayJR , CampSYet al. Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma. JAMA324(19), 1957–1969 (2020).
   PubMed Web of Science ®Google Scholar
• Thorvaldsdóttir H , RobinsonJT , MesirovJP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform.14(2), 178–192 (2013).
   PubMed Web of Science ®Google Scholar
• McLaren W , GilL , HuntSEet al. The Ensembl variant effect predictor. Genome Biol.17(1), 122 (2016).
   PubMed Web of Science ®Google Scholar
• Landrum MJ , LeeJM , BensonMet al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res.46(D1), D1062–D1067 (2018).
   PubMed Web of Science ®Google Scholar
• Lee S-B , WheelerMM , PattersonKet al. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model. Genet. Med.21(2), 361–372 (2019).
   PubMed Web of Science ®Google Scholar
• Twesigomwe D , WrightGEB , DrögemöllerBI , da RochaJ , LombardZ , HazelhurstS. A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping. NPJ Genom. Med.5, 30 (2020).
   PubMed Web of Science ®Google Scholar
• Weinstein JN , CollissonEA , MillsGBet al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet.45(10), 1113–1120 (2013).
   PubMed Web of Science ®Google Scholar
• Van Rossum G , DrakeFL. Python 3 Reference Manual: (Python Documentation Manual Part 2). CreateSpace Independent Publishing Platform,CA, USA (2009).
   Google Scholar
• Waskom M . Seaborn: statistical data visualization. J. Open Source Softw.6(60), 3021 (2021).
   Google Scholar
• Cerami E , GaoJ , DogrusozUet al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov.2(5), 401–404 (2012).
   PubMed Web of Science ®Google Scholar
• Gao J , AksoyBA , DogrusozUet al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal.6(269), l1 (2013).
   Web of Science ®Google Scholar
• Karczewski KJ , FrancioliLC , TiaoGet al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature581(7809), 434–443 (2020).
   PubMed Web of Science ®Google Scholar
• Song L , BaiG , LiuXS , LiB , LiH. T1K: efficient and accurate KIR and HLA genotyping with next-generation sequencing data.bioRxiv doi: https://doi.org/10.1101/2022.10.26.513955 (2022).
   Google Scholar
• Gaedigk A , Ingelman-SundbergM , MillerNAet al. The Pharmacogene Variation (PharmVar) Consortium: incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database. Clin. Pharmacol. Ther.103(3), 399–401 (2018).
   PubMed Web of Science ®Google Scholar
• Turner AJ , AggarwalP , BooneECet al. Identification of CYP2D6 haplotypes that interfere with commonly used assays for copy number variation characterization. J. Mol. Diagn.23(5), 577–588 (2021).
   PubMed Web of Science ®Google Scholar
• McLellan RA , OscarsonM , SeidegårdJ , EvansDA , Ingelman-SundbergM. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics7(3), 187–191 (1997).
   PubMedGoogle Scholar
• Al-Dosari MS , Al-JenoobiFI , AlkharfyKMet al. High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians. Environ. Toxicol. Pharmacol.36(3), 1063–1067 (2013).
   PubMed Web of Science ®Google Scholar
• Kircher M , WittenDM , JainP , O’RoakBJ , CooperGM , ShendureJ. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet.46(3), 310–315 (2014).
   PubMed Web of Science ®Google Scholar
• Zhou Y , MkrtchianS , KumondaiM , HiratsukaM , LauschkeVM. An optimized prediction framework to assess the functional impact of pharmacogenetic variants. Pharmacogenomics J.19(2), 115–126 (2019).
   PubMed Web of Science ®Google Scholar
• O’Donnell PH , DolanME. Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy. Clin. Cancer Res.15(15), 4806–4814 (2009).
   PubMed Web of Science ®Google Scholar
• Goetz MP , SangkuhlK , GuchelaarH-Jet al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy. Clin. Pharmacol. Ther.103(5), 770–777 (2018).
   PubMed Web of Science ®Google Scholar